New light on glaucoma gene discoveries
Globally 78 million people have glaucoma. That is one in every 200 people aged 40, which rises to one in eight by age 80 – and […]
Globally 78 million people have glaucoma. That is one in every 200 people aged 40, which rises to one in eight by age 80 – and […]
Early detection, increased screening and improved treatment options that combat diabetic retinopathy (DR), a leading cause of blindness in South Australian Aboriginal communities, is the aim […]
Researchers have identified 107 genes that increase a person’s risk of developing the eye disease glaucoma, and now developed a genetic test to detect those at […]
Increasing levels of poor sleep and sleep disorders affects at least one in five Australians, leading to an estimated $66 billion a year in lost productivity […]
Confirmation of 40 new genetic markers takes forward the development of the first tests to assess a person’s risk of developing glaucoma, a leading cause of […]
Flinders is at the forefront of finding solutions for glaucoma, the leading cause of irreversible blindness worldwide. By 2020, glaucoma will affect 80 million people worldwide, […]
From diabetes, cancer and heart disease to chronic pain and major depression, 12 new research grants announced today cap off a big year for Flinders medical […]
Ophthalmology experts at Flinders have played a pivotal role in discovering a new genetic cause for primary congenital glaucoma – a leading cause of blindness in children.
The discovery of new genetic areas linked to an increased risk of glaucoma will help prevent one of the leading cause of irreversible blindness in Asia.